July 21, 2026 · Press release
Cancer Cell Diagnostics (CCDx) Debuts Whole-Cell Genomic Profiling to Redefine Liquid Biopsy
CCDx announces the commercial launch of CellSight™ DNA, a 500+ gene comprehensive genomic profiling test performed on intact circulating tumor cells rather than fragmented cell-free DNA. Read more